Compare Himalaya Energi Perkasa Tbk. (HADE) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Himalaya Energi Perkasa Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Himalaya Energi Perkasa Tbk. trades at Rp18 (market cap 38.16B, 4.94M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 216.9K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 329.7× Himalaya Energi Perkasa Tbk.'s market cap, and Himalaya Energi Perkasa Tbk. is more actively traded (4.94M versus 216.9K). Which is the better fit depends on your goals.
| HADE | TSPC | |
|---|---|---|
Market Cap | 38.16B | 12.58T |
Volume | 4.94M | 216.9K |
Lot | 49.35K | 2.17K |
Turnover | 84.49M | 599M |
Average Price | 17.12 | 2,761.65 |
Value | 84.49M | 599M |
Indicative Equilibrium Price | 18 | 2,790 |
Indicative Equilibrium Volume | 5.87K | 3.9K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Himalaya Energi Perkasa Tbk.
PT HD Capital Tbk formerly PT Hortus Danavest Tbk. (the Company) was established under the name of PT Harumdana Sekuritas based on the Notarial Deed No. 24 dated February 10th, 1989 of Soebagjo Ronoatmodjo S.H., notary in Jakarta. The Company divides business into 3 divisions, Stock Brokerage & Trading Division, Corporate Finance & Investment Banking and Fixed Income Division. The Company is member of Jakarta Stock Exchange and Surabaya Stock Exchange.
Read more on HADE →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
